wwuhblzo.cfd Open in urlscan Pro
2606:4700:3030::6815:5903  Public Scan

Form analysis
0 forms found in the DOM

Text Content

Skip to content
 * BP + Health
 * Our Pipeline
   * Our Pipeline
   * Boppli™
   * Bosimi™
   * Bosimi@Home™ Monitoring
 * Our Company
 * News & Updates
 * Contact Us



CONTINUOUS NON‑INVASIVE BLOOD PRESSURE MONITORING (CNIBP)


BLOOD PRESSURE IS
WHERE ALL TREATMENT
DECISIONS BEGIN.

Accurate measurement of blood pressure is an important component of patient
care. At PyrAmes, we are developing accurate, non-invasive, wireless BP
monitoring for patients of all ages, from newborns to seniors.


ABOUT PYRAMES & OUR TECHNOLOGY


OUR PLATFORMS

 * Boppli™ Platform
 * Bosimi™ Platform
 * Bosimi@Home™ Platform


PRESENTING BOPPLI™

Accurate1, non-invasive, continuous, wireless BP monitoring for neonatal and
pediatric patients.

Learn More


PRESENTING BOSIMI™

Adult inpatient and emergency care cNIBP.

Learn More


PRESENTING BOSIMI@HOME™

Diagnostics, treatment validation & home medical management.

Learn More


CNIBP HEALTH IMPACT

PyrAmes platforms will provide options to continuously monitor blood pressure
cNIBP for patients of all ages.


OVER 50% OF NICU ADMISSIONS

could benefit from BP monitoring but would not receive an arterial line because
it is invasive and costly.2


50% OF ADULTS HAVE HIGH BP

50% of adults are affected by high blood pressure in the US, increasing their
mortality rates.3


7.6 MILLION DEATHS ANNUALLY

Raised blood pressure (BP) is responsible for 7.6 million deaths worldwide
annually.4


CNIBP & EARLY DETECTION

cNIBP has the potential for early detection of conditions within preterm infants
and adults.

1. Quan, X.; Liu, J.; Roxlo, T.; Siddharth, S.; Leong, W.; Muir, A.; Cheong,
S.-M.; Rao, A. Advances in Non-Invasive Blood Pressure Monitoring. Sensors 2021,
21, 4273. https://doi.org/10.3390/s21134273

2. Haidari, E. S., Lee, H. C., Illuzzi, J. L., Phibbs, C. S., Lin, H., & Xu, X.
(2020). Hospital variation in admissions to neonatal intensive care units by
diagnosis severity and category. Journal of Perinatology,
doi:10.1038/s41372-020-00775-z

3. https://www.cdc.gov/bloodpressure/facts.htm

4. https://pubmed.ncbi.nlm.nih.gov/22157565/


NEWS & UPDATES

MAY 1, 2023

PYRAMES INC. ANNOUNCES INVESTMENT FROM MARCH OF DIMES TO SUPPORT MATERNAL AND
PEDIATRIC HEALTH PRODUCTS

CUPERTINO, CA and ARLINGTON, VA — PyrAmes Inc. has received an investment from
March of Dimes, the leading organization fighting for the health of moms and
babies, to support development and commercialization of its wearable technology
to noninvasively monitor blood pressure, particularly for new mothers and their
babies. PyrAmes' goal is to develop more convenient, clinically-accurate, blood
pressure monitoring for all patients, including both mothers and babies in order
to support enhancing their health before and after childbirth. PyrAmes’ Boppli™
device for critically-ill infants received Breakthrough Device Designation from
the US Food & Drug Administration (FDA). (more…)

APRIL 27, 2023

INTERNATIONAL JOURNAL SENSORS HIGHLIGHTS PYRAMES’ TECHNOLOGY IN NEONATAL
CLINICAL STUDY

PyrAmes’ innovative Boppli™ blood pressure device is featured in the journal
Sensors, in a paper reporting a clincal study of 81 infants undergoing critical
care at Lucile Packard Children’s Hospital Stanford. Sensors is a leading
international, peer-reviewed journal on the science and technology of sensors.
The paper, Clinical Study of Continuous Non-Invasive Blood Pressure Monitoring
in Neonates, highlights the performance of PyrAmes’ novel algorithm-based blood
pressure sensor. Boppli is designed to meet the blood pressure monitoring
requirements and physical dimensions of small, prematurely-born infants, without
external calibration. Boppli uses machine-learning techniques to extract blood
pressure values from the shape of the pulse waveform, and is currently being
considered for market clearance by the FDA as a Class II medical device. The
paper indicates the use of Boppli is feasible for critically ill term and
preterm infants with a wide variety of pathologies—from serious cardiac
ailments, pre- and post-operative cases, neurologic conditions, and prematurity.

APRIL 4, 2023

PYRAMES SELECTED FOR NIH RADX TECH FOR MATERNAL HEALTH CHALLENGE FINAL PHASE

PyrAmes is among only 10 companies chosen to enter the final Technology
Assessment phase of the National Institutes of Health (NIH) RADx Tech for
Maternal Health Challenge. The goal of the RADx Challenge is to improve maternal
health outcomes for those who live in areas lacking access to maternity care
through innovative promising home-based or point-of-care diagnostic devices,
wearables, and other remote sensing technologies. PyrAmes’ submission,
Non-invasive, Continuous Blood Pressure Monitoring for Postpartum Maternal
Health, focuses on its Bosimi™ platform, a noninvasive, wearable sensor designed
to monitor blood pressure of women in their postpartum period, when the risk of
maternal mortality is highest. (more…)

View All News

2020 FDA Breakthrough Device Designation

Founding Member of CDC National Hypertension Control Roundtable

2020 SWPDC Pediatric Device Award, Member of SWPDC

2019 MedTech Innovator Accelerator & 2020 NCC-PDI MedTech Innovator Pediatric
Accelerator

Exponential Medicine 2019 One to Watch Award

×

PyrAmes is a digital health company focused on fundamentally transforming the
delivery of health care through continuous blood pressure monitoring that is
accurate, wireless and non-invasive. The comfort and ease of use of our platform
has the potential to provide better blood pressure management for patients
ranging from newborns to seniors. The FDA has granted Breakthrough Device
Designation for our lead product Boppli™. The Boppli™, Bosimi™, and Bosimi@Home™
platforms are currently under development and have not yet been cleared by the
FDA for distribution.

 * Contact Us

 * 
 * 

 * Privacy Policy

PYRAMES INC. REV 01

PyrAmes, Inc.
21730 Stevens Creek Blvd.
Suite 201A
Cupertino, CA 95014

Created by Howbridge © 2023 PyrAmes Inc. All rights reserved.

X

THIS WEBSITE USES COOKIES TO IMPROVE FUNCTIONALITY AND PERFORMANCE. IF YOU
CHOOSE TO CONTINUE BROWSING THIS WEBSITE, YOU ARE GIVING IMPLIED CONSENT TO THE
USE OF COOKIES.

Read MoreReject AllAcceptCookie Settings
Manage consent
Close

PRIVACY OVERVIEW

This website uses cookies to improve your experience while you navigate through
the website. Out of these, the cookies that are categorized as necessary are
stored on your browser as they are essential for the working of basic
functionalities of the ...
Necessary
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly.
These cookies ensure basic functionalities and security features of the website,
anonymously.

CookieDurationDescriptioncookielawinfo-checkbox-analytics11 monthsThis cookie is
set by GDPR Cookie Consent plugin. The cookie is used to store the user consent
for the cookies in the category "Analytics".cookielawinfo-checkbox-functional11
monthsThe cookie is set by GDPR cookie consent to record the user consent for
the cookies in the category "Functional".cookielawinfo-checkbox-necessary11
monthsThis cookie is set by GDPR Cookie Consent plugin. The cookies is used to
store the user consent for the cookies in the category
"Necessary".cookielawinfo-checkbox-others11 monthsThis cookie is set by GDPR
Cookie Consent plugin. The cookie is used to store the user consent for the
cookies in the category "Other.cookielawinfo-checkbox-performance11 monthsThis
cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the
user consent for the cookies in the category
"Performance".viewed_cookie_policy11 monthsThe cookie is set by the GDPR Cookie
Consent plugin and is used to store whether or not user has consented to the use
of cookies. It does not store any personal data.

Functional
functional
Functional cookies help to perform certain functionalities like sharing the
content of the website on social media platforms, collect feedbacks, and other
third-party features.
Performance
performance
Performance cookies are used to understand and analyze the key performance
indexes of the website which helps in delivering a better user experience for
the visitors.
Analytics
analytics
Analytical cookies are used to understand how visitors interact with the
website. These cookies help provide information on metrics the number of
visitors, bounce rate, traffic source, etc.
Advertisement
advertisement
Advertisement cookies are used to provide visitors with relevant ads and
marketing campaigns. These cookies track visitors across websites and collect
information to provide customized ads.
Others
others
Other uncategorized cookies are those that are being analyzed and have not been
classified into a category as yet.
Save & Accept